CLOs on the Move

ContextVision

www.contextvision.com

 
ContextVision is a leading provider of medical image enhancement software to global equipment manufacturers. With its versatile GOP® technology at the core of its extensive product line, ContextVision enables its customers to offer clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision was established in 1983 by a specialist research team at Linköping University in Sweden. The university has been a center for digital image research and analysis. ContextVision, now considered the gold standard of medical image enhancement, offers a powerful combination of sophisticated technology and team expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, interventional radiology ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Bay Shore Medical

Bay Shore Medical is a Ronkonkoma, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sanuwave

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.

Prestige Medical

Prestige Medical is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Conmed

Conmed, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures and monitoring in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. The company offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, clip appliers, scissors, and surgical staplers used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, the company provides mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and polypectomy; pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; suction instruments and tubing for use in the operating room; IV products for use in the critical care areas of the hospital; pulmonary monitoring products; and imaging systems for use in the minimally invasive orthopedic and general surgery procedures. The company’s products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

VisCardia

VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.